|
|
||||||||
Department of Physiology, McGill University, Montréal, Québec, Canada. linsdell@medcor.mcgill.ca
1. The disulphonic stilbenes 4,4'-dinitrostilbene-2,2'-disulphonic acid (DNDS) and 4,4'-diisothiocyanostilbene-2,2'-disulphonic acid (DIDS) were shown to cause a voltage-dependent inhibition of macroscopic cystic fibrosis transmembrane conductance regulator (CFTR) Cl- currents expressed in baby hamster kidney cells when applied to the cytoplasmic face of the membrane. These compounds are known to be relatively ineffective at blocking CFTR from the extracellular side of the membrane. 2. Mutation of a positively charged arginine, previously suggested to be located in the channel pore (R347), to a negatively charged aspartate significantly reduced the affinity of block by both DNDS and DIDS, suggesting that this residue contributes to the binding site for disulphonic stilbenes. 3. It is suggested that the CFTR Cl- channel may contain a relatively large inner vestibule in which a number of large anions bind and block Cl- permeation. Arginine 347 may be involved in anion binding within this region.
This article has been cited by other articles:
![]() |
T.-Y. Chen and T.-C. Hwang CLC-0 and CFTR: Chloride Channels Evolved From Transporters Physiol Rev, April 1, 2008; 88(2): 351 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Laver and K. M. Bradley Disulfonic stilbene permeation and block of the anion channel from the sarcoplasmic reticulum of rabbit skeletal muscle Am J Physiol Cell Physiol, June 1, 2006; 290(6): C1666 - C1677. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. A. Assef, A. E. Damiano, E. Zotta, C. Ibarra, and B. A. Kotsias CFTR in K562 human leukemic cells Am J Physiol Cell Physiol, August 1, 2003; 285(2): C480 - C488. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Cai and D. N. Sheppard Phloxine B Interacts with the Cystic Fibrosis Transmembrane Conductance Regulator at Multiple Sites to Modulate Channel Activity J. Biol. Chem., May 24, 2002; 277(22): 19546 - 19553. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |